Several examples in which high IFN states caused collapsing glomerulopathy in carriers of a high-risk APOL1 genotype led to a paradigm that pointed to IFNs as the chief “second-hit” triggers of APOL1-mediated glomerulopathy (31, 36, 37). This evidence concerns the gene APOL1 and lipoprotein glomerulopathy.